Georgina H Mason

Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity

A. Parker, A. Godkin, A. Gallimore, 2021, Immunology.

CD4+ T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features

A. Sewell, G. Dolton, P. Rizkallah, 2020, Cell reports.

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope

T. Elliott, A. Sewell, G. Dolton, 2019, The Journal of Biological Chemistry.

Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity

A. Godkin, A. Gallimore, B. MacLachlan, 2021, Immunotherapy advances.

Molecular characterization of HLA class II binding to the LAG‐3 T cell co‐inhibitory receptor

D. Cole, A. Greenshields-Watson, A. Godkin, 2020, European journal of immunology.

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

A. Sewell, P. Rizkallah, D. Cole, 2017, Journal of visualized experiments : JoVE.

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity

A. Sewell, P. Rizkallah, A. Greenshields-Watson, 2023, Cell reports.

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope

T. Elliott, A. Sewell, G. Dolton, 2019, The Journal of Biological Chemistry.